OTUD1通过对STAT3进行脱化来降低PD-L1的表达,并促进CcRCCCC中的免疫反应
Huaiyuan Liang1,2, Xinlin Liu1,2, Wanyang Guo1,2
1Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Cellular oncology (Dordrecht, Netherlands)
|June 12, 2025
概括
研究人员发现,OTUD1抑制PD-L1并通过稳定STAT3.3来增强清细胞细胞癌 (ccRCC) 的抗瘤免疫力. 这一发现为改善ccRCC患者免疫疗法反应提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 清细胞细胞癌 (ccRCC) 的死亡率很高,免疫疗法由于免疫逃脱而提供有限的益处.
- 了解免疫逃逸的机制对于开发高级ccRCC的有效治疗方法至关重要.
研究的目的:
- 调查OTUD1在ccRCC免疫逃避中的作用.
- 探索OTUD1作为增强ccRCC免疫疗法的潜在治疗标.
主要方法:
- 使用TCGA,GEO数据集和cBioPortal对ccRCC中OTUD1表达的分析.
- 建立一个小鼠模型来研究OTUD1对抗PD-1治疗的影响.
- 使用co-IP,流细胞计和RNA-seq通过STAT3.3阐明OTUD1的机制.
主要成果:
- OTUD1抑制PD-L1的表达,并通过对STAT3.3进行脱化和稳定,增强ccRCC中的抗瘤免疫力.
- OTUD1 抑制了 STAT3 核转位和转录活动,破坏了 PD-1/PD-L1 介导的免疫逃避.
- OTUD1-STAT3-PD-L1轴代表了克服ccRCC中免疫检查点抵抗的新机制.
结论:
- OTUD1与STAT3相互作用,使其脱,并抑制其核转位和活性.
- 通过OTUD1降低PD-L1的调节最终会抑制ccRCC的免疫逃避,这表明OTUD1是治疗点.
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961


